Needham upgraded Boston Scientific (BSX) to Buy from Hold with a $113 price target
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BSX:
- Boston Scientific price target lowered to $113 from $120 at Truist
- Microsoft removed from ‘US 1 List’ at BofA
- Unusually active option classes on open April 4th
- Needham medtech & diagnostics analyst holds analyst/industry conference call
- Boston Scientific’s Growth Prospects Bolstered by FDA Clearance and Successful Trials for Bolt IVL System